EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Antifibrotic Effects of Drugs Commonly Used in Inflammatory Intestinal Diseases on In Vitro Intestinal Cellular Models

Serena Artone, Alessia Ciafarone iD, Francesca Rosaria Augello, Francesca Lombardi iD, Maria Grazia Cifone iD, Paola Palumbo iD, Benedetta Cinque, Giovanni Latella iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Serena Artone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health & Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building Rita Levi Montalcini, Coppito, 67100 L'Aqu…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Inflammatory Bowel Diseases, Fibrosis, Transforming Growth Factor beta1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Life, Health & Environmental Sciences, University of L'Aquila, Department of Life, Health & Environmental Sciences, University of L’Aquila.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism underlying intestinal fibrosis, the main complication of inflammatory bowel disease (IBD), is not yet fully understood, and there is no therapy to prevent or reverse fibrosis. We evaluated, in in vitro cellular models, the ability of different classes of drugs currently used in IBD to counteract two pivotal processes of intestinal fibrosis, the differentiation of intestinal fibroblasts to activated myofibroblasts using CCD-18Co cells, and the epithelial-to-mesenchymal transition (EMT) of intestinal epithelial cells using Caco-2 cells (IEC), both being processes induced by transforming growth factor-β1 (TGF-β1). The drugs tested included mesalamine, azathioprine, methotrexate, prednisone, methylprednisolone, budesonide, infliximab, and adalimumab. The expression of fibrosis and EMT markers (collagen-I, α-SMA, pSmad2/3, occludin) was assessed by Western blot analysis and by immunofluorescence. Of the drugs used, only prednisone, methylprednisolone, budesonide, and adalimumab were able to antagonize the pro-fibrotic effects induced by TGF-β1 on CCD-18Co cells, reducing the fibrosis marker expression. Methylprednisolone, budesonide, and adalimumab were also able to significantly counteract the TGF-β1-induced EMT process on Caco-2 IEC by increasing occludin and decreasing α-SMA expression. This is the first study that evaluates, using in vitro cellular models, the direct antifibrotic effects of drugs currently used in IBD, highlighting which drugs have potential antifibrotic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionInflammatory Bowel DiseasesFibrosisTransforming Growth Factor beta1BudesonideHumansCaco-2 CellsAdalimumabIntestinal MucosaMethylprednisoloneMesalaminePrednisoneMyofibroblastsAnti-Inflammatory AgentsInfliximabAzathioprineMethotrexateIntestinesCell Differentiation

Stichwörter der Autor:innen

CCD-18Co cellsCaco-2 IECEMTIBDSmad 2/3TGF-β1collagen-Iintestinal fibrosisoccludinα-SMA

Substanzen

Transforming Growth Factor beta1BudesonideAdalimumabMethylprednisoloneMesalaminePrednisoneAnti-Inflammatory AgentsInfliximabAzathioprineMethotrexate

Autor:innen und Institutionen

  • Department of Life, Health & Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building Rita Levi Montalcini, Coppito, 67100 L'Aquila, Italy.
  • PhD School in Medicine and Public Health, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • PhD School in Health & Environmental Sciences, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Unit of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health & Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building Rita Levi Montalcini, Coppito, 67100 L'Aquila, Italy.

ORCID-Profile: Alessia Ciafarone, Francesca Lombardi, Maria Grazia Cifone, Paola Palumbo, Giovanni Latella

Förderung

  • Department of Life, Health & Environmental Sciences, University of L'Aquila
  • Department of Life, Health & Environmental Sciences, University of L’Aquila

Zitieren

APA

Artone, S., Ciafarone, A., Augello, F. R., Lombardi, F., Cifone, M. G., Palumbo, P., Cinque, B., & Latella, G. (2024). Evaluation of the Antifibrotic Effects of Drugs Commonly Used in Inflammatory Intestinal Diseases on In Vitro Intestinal Cellular Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168862

Vancouver

Artone S, Ciafarone A, Augello FR, Lombardi F, Cifone MG, Palumbo P, et al. Evaluation of the Antifibrotic Effects of Drugs Commonly Used in Inflammatory Intestinal Diseases on In Vitro Intestinal Cellular Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168862

BibTeX
@article{Artone2024,
  author = {Artone, Serena and Ciafarone, Alessia and Augello, Francesca Rosaria and Lombardi, Francesca and Cifone, Maria Grazia and Palumbo, Paola and Cinque, Benedetta and Latella, Giovanni},
  title = {Evaluation of the Antifibrotic Effects of Drugs Commonly Used in Inflammatory Intestinal Diseases on In Vitro Intestinal Cellular Models},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168862}
}
Kostenlos starten →